Dr. Chancellor is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3535 W 13 Mile Rd
Ste 404
Royal Oak, MI 48073Phone+1 248-551-3535Fax+1 248-551-3311- Is this information wrong?
Education & Training
New York Presbyterian Hospital (Columbia Campus)Residency, Urology, 1989 - 1990
University of Michigan Health SystemResidency, Urology, 1985 - 1988- University of Michigan Health SystemResidency, Surgery, 1983 - 1985
Medical College of WisconsinClass of 1983
Certifications & Licensure
NY State Medical License 1989 - Present
NJ State Medical License 1988 - Present
TX State Medical License 2024 - 2024
MI State Medical License 1984 - 2024
WV State Medical License 2000 - 2020
MS State Medical License 1983 - 2019
AR State Medical License 2007 - 2019- American Board of Urology Urology
- Join now to see all
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2006-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
- Pittsburgh Magazine Castle Connolly, 2005-2008
Publications & Presentations
PubMed
- Preventing the 17-Year Gap in Overactive Bladder Prescribing Practices: The Need for Implementation Science.Michael B Chancellor> ;Urology Practice. 2024 Mar 1
- Identification of Molecular Mechanisms in Radiation Cystitis: Insights from RNA Sequencing.Sabrina Mota, Elijah P Ward, Sarah N Bartolone, Michael B Chancellor, Bernadette M M Zwaans> ;International Journal of Molecular Sciences. 2024 Feb 23
- Oxybutynin-associated Cognitive Impairment: Evidence and Implications for Overactive Bladder Treatment.Michael B Chancellor, Alvaro Lucioni, David Staskin> ;Urology. 2024 Jan 29
- Join now to see all
Press Mentions
COVID-19-Associated Cystitis Linked to Inflammatory Biomarkers in UrineSeptember 12th, 2021- Beaumont Team Develops Technology for 45-Minute COVID-19 TestJuly 7th, 2020
Underactive Bladder; Review of Progress and Impact from the International CURE-UAB InitiativeMarch 12th, 2020- Join now to see all
Grant Support
- Pharmacology Of Intravesical Antisense Based Therapy For Over Active BladderNational Institute Of Diabetes And Digestive And Kidney Diseases2011
- Intravesical Liposome Drug Delivery To Treat Interstitial CystitisNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
- Functional Tissue Engineering For Stress IncontinenceNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2005–2006
- Urologic Training Program For Physicians And ScientistsNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2006
- Collaborative Urological Research In Spinal Cord InjuryEunice Kennedy Shriver National Institute Of Child Health &Human Development2001–2005
- Muscle Cells Mediated Gene Therapy For IncontinenceNational Institute Of Diabetes And Digestive And Kidney Diseases1998–2005
- Diabetic Bladder Afferent Neuron And NGF Gene TherapyNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2004
- Urologic Training Program For Physicians And ScientistsNational Institute Of Diabetes And Digestive And Kidney Diseases1999–2003
- Urologic Training Prog For Physicians And ScientistsNational Institute Of Diabetes And Digestive And Kidney Diseases1999–2003
- Novel Intervention Strategies For Neurogenic BladderEunice Kennedy Shriver National Institute Of Child Health &Human Development2001–2002
- Pittsburgh Incontinence Collaborative Treatment ProgramNational Institute Of Diabetes And Digestive And Kidney Diseases2000
- Comparison Of Sphincter Prosthesis And SphincterotomyEunice Kennedy Shriver National Institute Of Child Health &Human Development1993–1995
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
